KALV
KalVista Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.00
+0.00%Latest reported
- Last report date
- May 15, 2026
- EPS actual
- -$0.92
- EPS estimate
- -$0.38
- Revenue actual
- $13.7M
- Revenue estimate
- $39.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -64.5%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 15, 2026 | -$0.38 | -$0.92 | Miss -144.52% | $13.7M |
| Mar 24, 2026 | -$0.54 | -$1.01 | Miss -87.04% | $1.4M |
| Sep 11, 2025 | -$0.91 | -$1.12 | Miss -23.08% | $1.4M |
| Mar 12, 2025 | -$0.89 | -$0.92 | Miss -3.37% | — |
| Dec 5, 2024 | -$0.91 | -$0.91 | In line | — |
| Sep 5, 2024 | -$0.91 | -$0.87 | Beat 4.40% | — |
| Mar 11, 2024 | -$0.77 | -$0.84 | Miss -9.09% | — |
| Dec 7, 2023 | -$0.79 | -$0.80 | Miss -1.27% | — |
| Sep 7, 2023 | -$0.86 | -$0.74 | Beat 13.95% | — |
| Mar 9, 2023 | -$0.97 | -$0.75 | Beat 22.68% | — |
| Dec 8, 2022 | -$1.06 | -$0.90 | Beat 15.09% | — |
| Sep 8, 2022 | -$1.04 | -$0.94 | Beat 9.62% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 15, 2026